Ledger.Open graph →
SEC Form D · filed August 31, 2020

Gilgamesh Pharmaceuticals, Inc

Offering
—
Sold
$125K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LINVILLE, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Dalibor Sames · New York, NYDirectorJonathan Sporn · New York, NYExec · DirectorAndrew Kruegel · New York, NYDirectorGautam Shah · Cedar Park, TXDirectorEdward Harycki · Bryn Mawr, PAExec · DirectorJulie B. Sanders · Dallas, TXDirectorKent Gordon · Salt Lake City, UTDirectorJames T. Farrell · San Francisco, CADirectorGaurav Sahni · Short Hills, X1Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗